Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Sex Differences in Faculty Rank and Leadership Positions Amongst Hematologists and Oncologists in United States: A Cross-Sectional Study

Irbaz Riaz, MDMMSc, Rabbia Siddiqi, MBBS, Umar Zahid, MD MPH, Urshila Durani, MDMPH, Kaneez Fatima, MD, Qurat Ul Ain Riaz Sipra, MBBS, MD, Ammad Raina, DO, Muhammad Zain Farooq, MD MBBS, Alanna Chamberlain, Zhen Wang, Ronald S. Go, MD, Faisal Khosa, MD, Ariela L. Marshall, MD

Blood (2019) 134 (Supplement_1): 3399.

https://doi.org/10.1182/blood-2019-130670

Published: 2019

Journal Articles

The Healthcare Burden of Emergency Department Utilization for Multiple Myeloma: A Five Years U.S. Nationwide Study

Mohamed Mokhtar Bakr, MD, Umar Zahid, MD MPH, Pavan Tenneti, MD, Rehan Farooqi, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 3562.

https://doi.org/10.1182/blood-2018-99-119932

Published: 2018

Journal Articles

Pomalidomide Based Regimens for Treatment of Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials

Adeela Mushtaq, MD, Ahmad Iftikhar, MD, Midhat Lakhani, MD, Fnu Sagar, MD, Ahmad Kamal, MD, Umar Zahid, MD MPH, Hamza Hassan, MD, Zeeshan Ali, MD, Faryal Razzaq, MBBS, Saad Ullah Malik, MD, Syeda Fatima Hassan, MBBS, Muhammad Abu Zar, MD, Mohammad Bilal Chaudhary, MD, Ahmad Safdar, Mohamed Mokhtar Bakr, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 2022.

https://doi.org/10.1182/blood-2018-99-111439

Published: 2018

Journal Articles

Survival Benefit of Novel Drug Combinations Using Hypomethylating Agents for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Systemic Review

Pavan Tenneti, MD, Keri R Maher, DO, Mohamed Mokhtar Bakr, MD, Umar Zahid, MD MPH, Saad Ullah Malik, MD, Warda Faridi, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5182.

https://doi.org/10.1182/blood-2018-99-115810

Published: 2018

Journal Articles

National Trends in Leukemia Related Emergency Department Visits, Health Care Burden and Disposition Rate in the United States, 2010-2014

Mohamed Mokhtar Bakr, MD, Umar Zahid, MD MPH, Pavan Tenneti, MD, Alsadiq Waleed Al-Hillan, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 4695.

https://doi.org/10.1182/blood-2018-99-117879

Published: 2018

Journal Articles

Efficacy and Toxicity Profile of Elotuzumab for Multiple Myeloma: A Systematic Review and Meta-Analysis

Faiza Jamil, MD, Madeeha Shafqat, Sharoon Samuel, MBBS, Zunairah Shah, MBBS, Ceren Durer, MD, Seren Durer, MD, Maryam Sadiq, MBBS, Muhammad Junaid Tariq, MD, Jemin Aby Jose, MD, Warda Faridi, MD, Mohamed Mokhtar Bakr, MD, Umar Zahid, MD, Ali McBride, PharmD, MS, Ahmad Safdar, BS, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5640.

https://doi.org/10.1182/blood-2018-99-117209

Published: 2018

Journal Articles

Gender Differences in Faculty Rank, Departmental Leadership, and Research Output Amongst Hematology/Oncology Faculty in United States

Irbaz Bin Riaz, MDMMSc, Rabbia Siddiqi, MD, Kaneez Fatima, MD, Muhammad Shahzeb Khan, MD, Umar Zahid, MD, Faisal Khosa, MD

Blood (2017) 130 (Supplement 1): 3354.

https://doi.org/10.1182/blood.V130.Suppl_1.3354.3354

Published: 2017

Journal Articles

Does Your Smoldering Myeloma Patient Need Treatment? Evidence Based Recommendations

Rafiullah, MD, Umar Zahid, MD, Irbaz Bin Riaz, MDMMSc, Ali McBride, PharmD,MS, Ahmad Iftikhar, MD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Guido J. Tricot, MD PhD, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 5431.

https://doi.org/10.1182/blood.V130.Suppl_1.5431.5431

Published: 2017

Journal Articles

Role of High Dose Chemotherapy and Autologous Stem Cell Transplant in Relapsed Ewing's Sarcoma — a Systematic Review

Pavan Tenneti, MD, Umar Zahid, MD, Ahmad Iftikhar, MD, Seongseok Yun, MD PhD, Vikas Kapoor, MD, Azka Latif, MD, Adeela Mushtaq, MD, Raahem Nayab Zafar, BS, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 2014.

https://doi.org/10.1182/blood.V130.Suppl_1.2014.2014

Published: 2017

Journal Articles

RX-3117, a Novel Nucleoside Analog Targeting UCK2 Is Active Alone and Synergistic with Ibrutinib and Bendamustine in ABC and DH/DP- Diffuse Large B-Cell Lymphoma

Shariful Islam, Umar Zahid, MD, Laurence Cooke, MS, Young Bok Lee, Deog Joong Kim, Ely Benaim, MD, Daruka Mahadevan, MD PhD

Blood (2017) 130 (Supplement 1): 5196.

https://doi.org/10.1182/blood.V130.Suppl_1.5196.5196

Published: 2017

NARROW

Sex Differences in Faculty Rank and Leadership Positions Amongst Hematologists and Oncologists in United States: A Cross-Sectional Study

The Healthcare Burden of Emergency Department Utilization for Multiple Myeloma: A Five Years U.S. Nationwide Study

Pomalidomide Based Regimens for Treatment of Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials

Survival Benefit of Novel Drug Combinations Using Hypomethylating Agents for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Systemic Review

National Trends in Leukemia Related Emergency Department Visits, Health Care Burden and Disposition Rate in the United States, 2010-2014

Efficacy and Toxicity Profile of Elotuzumab for Multiple Myeloma: A Systematic Review and Meta-Analysis

Gender Differences in Faculty Rank, Departmental Leadership, and Research Output Amongst Hematology/Oncology Faculty in United States

Does Your Smoldering Myeloma Patient Need Treatment? Evidence Based Recommendations

Role of High Dose Chemotherapy and Autologous Stem Cell Transplant in Relapsed Ewing's Sarcoma — a Systematic Review

RX-3117, a Novel Nucleoside Analog Targeting UCK2 Is Active Alone and Synergistic with Ibrutinib and Bendamustine in ABC and DH/DP- Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only